Chiome the latest Japanese bioventure to head to market
This article was originally published in Scrip
Executive Summary
The Japanese bioventure Chiome Bioscience has received approval to list on the Mothers market of the Tokyo Stock Exchange on 20 December, at a price yet to be determined.